Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis.
ERJ Open Res. 2023 Apr 3;9(2):00745-2022. doi: 10.1183/23120541.00745-2022. eCollection 2023 Mar.
ERJ Open Res. 2023.
PMID: 37020841
Free PMC article.
Real-World Effectiveness of Reslizumab in Patients With Severe Eosinophilic Asthma - First Initiators and Switchers.
Hashimoto S, Kroes JA, Eger KA, Mau Asam PF, Hofstee HB, Bendien SA, Braunstahl GJ, Broeders MEAC, Imming LM, Langeveld B, Maitland-van der Zee AH, Oud KTM, Patberg KW, Smeenk FWJM, Romme EAPM, van Bezouw MJ, van de Ven MJ, van Veen A, van Velzen E, van Veen IHPAA, Weersink EJM, Ten Brinke A, Sont JK, Bel EH; RAPSODI team.
Hashimoto S, et al. Among authors: hofstee hb.
J Allergy Clin Immunol Pract. 2022 Aug;10(8):2099-2108.e6. doi: 10.1016/j.jaip.2022.04.014. Epub 2022 Apr 26.
J Allergy Clin Immunol Pract. 2022.
PMID: 35487369
Free article.
Item in Clipboard
Cite
Cite